Search research articles
Contact Us
Filters
Showing results (31-40 of 109) with videos related to
Page
of 11
Sort By:
Cannabis and Cannabinoid Research
|
October 21, 2022
Hyperthermia-Induced Seizures Enhance Brain Concentrations of the Endocannabinoid-Related Linoleoyl Glycerols in a <i>Scn1a</i><sup>+/-</sup> Mouse Model of Dravet Syndrome
Dilara Bahceci, Lyndsey L Anderson, Richard C Kevin, et al.
Plos One
|
November 24, 2011
Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats
Michael T Bowen, Dean S Carson, Adena Spiro, et al.
Neuroscience Letters
|
November 7, 2019
P2X<sub>7</sub> receptor knockout mice display less aggressive biting behaviour correlating with increased brain activation in the piriform cortex
Kristie Leigh Smith, Stephanie M Todd, Aurelie Boucher, et al.
Behavioural Pharmacology
|
April 23, 2011
Disruptive effects of the prototypical cannabinoid Δ⁹-tetrahydrocannabinol and the fatty acid amide inhibitor URB-597 on go/no-go auditory discrimination performance and olfactory reversal learning in rats
Ljiljana Sokolic, Leonora E Long, Glenn E Hunt, et al.
British Journal of Pharmacology
|
March 28, 2022
Inhibition of human recombinant T-type calcium channels by phytocannabinoids in vitro
Somayeh Mirlohi, Chris Bladen, Marina J Santiago, et al.
Pharmacological Research
|
February 18, 2026
Urinary Δ<sup>9</sup>-tetrahydrocannabinol and metabolite concentrations following cannabis use: A systematic review
Danielle McCartney, Christopher Irwin, Jonathon C Arnold, et al.
Behavioural Pharmacology
|
June 3, 2020
Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice
Neda Assareh, Anand Gururajan, Cilla Zhou, et al.
The Medical Journal of Australia
|
August 11, 2018
Medicinal cannabis in Australia, 2016: the Cannabis as Medicine Survey (CAMS-16)
Nicholas Lintzeris, Jessica Driels, Natalie Elias, et al.
Journal of Natural Products
|
November 6, 2019
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome
Lyndsey L Anderson, Ivan K Low, Samuel D Banister, et al.
British Journal of Pharmacology
|
May 28, 2025
Cannabidiol dose dependently reduces alcohol intake in mice via a non-5-HT<sub>1A</sub> receptor mechanism: Exploration of other potential receptor targets
Connie J Badolato, Erin A Lynch, Jonathon C Arnold, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 109) with videos related to
Sort By:
Page
of 11
Cannabis and Cannabinoid Research
|
October 21, 2022
Hyperthermia-Induced Seizures Enhance Brain Concentrations of the Endocannabinoid-Related Linoleoyl Glycerols in a <i>Scn1a</i><sup>+/-</sup> Mouse Model of Dravet Syndrome
Dilara Bahceci, Lyndsey L Anderson, Richard C Kevin, et al.
Plos One
|
November 24, 2011
Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats
Michael T Bowen, Dean S Carson, Adena Spiro, et al.
Neuroscience Letters
|
November 7, 2019
P2X<sub>7</sub> receptor knockout mice display less aggressive biting behaviour correlating with increased brain activation in the piriform cortex
Kristie Leigh Smith, Stephanie M Todd, Aurelie Boucher, et al.
Behavioural Pharmacology
|
April 23, 2011
Disruptive effects of the prototypical cannabinoid Δ⁹-tetrahydrocannabinol and the fatty acid amide inhibitor URB-597 on go/no-go auditory discrimination performance and olfactory reversal learning in rats
Ljiljana Sokolic, Leonora E Long, Glenn E Hunt, et al.
British Journal of Pharmacology
|
March 28, 2022
Inhibition of human recombinant T-type calcium channels by phytocannabinoids in vitro
Somayeh Mirlohi, Chris Bladen, Marina J Santiago, et al.
Pharmacological Research
|
February 18, 2026
Urinary Δ<sup>9</sup>-tetrahydrocannabinol and metabolite concentrations following cannabis use: A systematic review
Danielle McCartney, Christopher Irwin, Jonathon C Arnold, et al.
Behavioural Pharmacology
|
June 3, 2020
Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice
Neda Assareh, Anand Gururajan, Cilla Zhou, et al.
The Medical Journal of Australia
|
August 11, 2018
Medicinal cannabis in Australia, 2016: the Cannabis as Medicine Survey (CAMS-16)
Nicholas Lintzeris, Jessica Driels, Natalie Elias, et al.
Journal of Natural Products
|
November 6, 2019
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome
Lyndsey L Anderson, Ivan K Low, Samuel D Banister, et al.
British Journal of Pharmacology
|
May 28, 2025
Cannabidiol dose dependently reduces alcohol intake in mice via a non-5-HT<sub>1A</sub> receptor mechanism: Exploration of other potential receptor targets
Connie J Badolato, Erin A Lynch, Jonathon C Arnold, et al.
Page
of 11